A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial(†)

AIMS: Clinical trials suggest that intracoronary delivery of autologous bone marrow-derived cells (BMCs) 1–7 days post-acute myocardial infarction (AMI) may improve left ventricular (LV) function. Earlier time points have not been evaluated. We sought to determine the effect of intracoronary autolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudry, Fizzah, Hamshere, Stephen, Saunders, Natalie, Veerapen, Jessry, Bavnbek, Katrine, Knight, Charles, Pellerin, Denis, Locca, Didier, Westwood, Mark, Rakhit, Roby, Crake, Tom, Kastrup, Jens, Parmar, Mahesh, Agrawal, Samir, Jones, Daniel, Martin, John, Mathur, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712349/
https://www.ncbi.nlm.nih.gov/pubmed/26405233
http://dx.doi.org/10.1093/eurheartj/ehv493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712349/
https://www.ncbi.nlm.nih.gov/pubmed/26405233
http://dx.doi.org/10.1093/eurheartj/ehv493

Ejemplares similares